vs
Side-by-side financial comparison of ORTHOPEDIATRICS CORP (KIDS) and Telesat Corp (TSAT). Click either name above to swap in a different company.
Telesat Corp is the larger business by last-quarter revenue ($73.8M vs $61.6M, roughly 1.2× ORTHOPEDIATRICS CORP). ORTHOPEDIATRICS CORP runs the higher net margin — -16.4% vs -119.8%, a 103.4% gap on every dollar of revenue. Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs -64.0%).
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
Telesat, formerly Telesat Canada, is a Canadian satellite communications company founded on May 2, 1969. The company is headquartered in Ottawa.
KIDS vs TSAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $73.8M |
| Net Profit | $-10.1M | $-88.4M |
| Gross Margin | 73.2% | 95.3% |
| Operating Margin | -13.3% | 5.9% |
| Net Margin | -16.4% | -119.8% |
| Revenue YoY | 17.0% | — |
| Net Profit YoY | 37.1% | — |
| EPS (diluted) | $-0.43 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | — | ||
| Q3 25 | $61.3M | $73.8M | ||
| Q2 25 | $61.1M | $77.5M | ||
| Q1 25 | $52.4M | $152.2M | ||
| Q4 24 | $52.7M | — | ||
| Q3 24 | $54.6M | — | ||
| Q2 24 | $52.8M | $363.2M | ||
| Q1 24 | $44.7M | — |
| Q4 25 | $-10.1M | — | ||
| Q3 25 | $-11.8M | $-88.4M | ||
| Q2 25 | $-7.1M | $55.1M | ||
| Q1 25 | $-10.7M | $-52.3M | ||
| Q4 24 | $-16.1M | — | ||
| Q3 24 | $-7.9M | — | ||
| Q2 24 | $-6.0M | $547.4M | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | 73.2% | — | ||
| Q3 25 | 73.9% | 95.3% | ||
| Q2 25 | 72.1% | 95.9% | ||
| Q1 25 | 73.0% | — | ||
| Q4 24 | 67.5% | — | ||
| Q3 24 | 73.4% | — | ||
| Q2 24 | 77.3% | — | ||
| Q1 24 | 72.0% | — |
| Q4 25 | -13.3% | — | ||
| Q3 25 | -15.4% | 5.9% | ||
| Q2 25 | -17.4% | 16.8% | ||
| Q1 25 | -21.0% | — | ||
| Q4 24 | -26.7% | — | ||
| Q3 24 | -10.2% | — | ||
| Q2 24 | -10.7% | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | -16.4% | — | ||
| Q3 25 | -19.2% | -119.8% | ||
| Q2 25 | -11.6% | 71.2% | ||
| Q1 25 | -20.3% | -34.4% | ||
| Q4 24 | -30.5% | — | ||
| Q3 24 | -14.5% | — | ||
| Q2 24 | -11.4% | 150.7% | ||
| Q1 24 | -17.5% | — |
| Q4 25 | $-0.43 | — | ||
| Q3 25 | $-0.50 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.46 | — | ||
| Q4 24 | $-0.70 | — | ||
| Q3 24 | $-0.34 | — | ||
| Q2 24 | $-0.26 | — | ||
| Q1 24 | $-0.34 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $352.3M |
| Total DebtLower is stronger | $106.0M | — |
| Stockholders' EquityBook value | $346.6M | $1.6B |
| Total Assets | $508.6M | $5.1B |
| Debt / EquityLower = less leverage | 0.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.9M | — | ||
| Q3 25 | $57.7M | $352.3M | ||
| Q2 25 | $70.1M | $399.6M | ||
| Q1 25 | $58.8M | $552.1M | ||
| Q4 24 | $68.8M | — | ||
| Q3 24 | $76.1M | — | ||
| Q2 24 | $28.9M | $1.7B | ||
| Q1 24 | $47.7M | — |
| Q4 25 | $106.0M | — | ||
| Q3 25 | $105.3M | — | ||
| Q2 25 | $102.7M | — | ||
| Q1 25 | $77.4M | — | ||
| Q4 24 | $77.5M | — | ||
| Q3 24 | $76.9M | — | ||
| Q2 24 | $11.2M | — | ||
| Q1 24 | $11.3M | — |
| Q4 25 | $346.6M | — | ||
| Q3 25 | $349.3M | $1.6B | ||
| Q2 25 | $355.5M | $1.7B | ||
| Q1 25 | $347.1M | $2.5B | ||
| Q4 24 | $354.6M | — | ||
| Q3 24 | $370.9M | — | ||
| Q2 24 | $371.3M | $2.4B | ||
| Q1 24 | $370.6M | — |
| Q4 25 | $508.6M | — | ||
| Q3 25 | $493.5M | $5.1B | ||
| Q2 25 | $503.6M | $4.9B | ||
| Q1 25 | $470.3M | $6.9B | ||
| Q4 24 | $473.2M | — | ||
| Q3 24 | $489.3M | — | ||
| Q2 24 | $430.8M | $6.3B | ||
| Q1 24 | $437.2M | — |
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.03× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.3M | — |
| Free Cash FlowOCF − Capex | $9.7M | — |
| FCF MarginFCF / Revenue | 15.8% | — |
| Capex IntensityCapex / Revenue | 1.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3M | — | ||
| Q3 25 | $-581.0K | — | ||
| Q2 25 | $-10.5M | — | ||
| Q1 25 | $-4.2M | — | ||
| Q4 24 | $-4.0M | — | ||
| Q3 24 | $-10.3M | — | ||
| Q2 24 | $-6.1M | — | ||
| Q1 24 | $-6.7M | — |
| Q4 25 | $9.7M | — | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $-13.9M | — | ||
| Q1 25 | $-8.4M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-11.7M | — | ||
| Q2 24 | $-12.8M | — | ||
| Q1 24 | $-13.2M | — |
| Q4 25 | 15.8% | — | ||
| Q3 25 | -5.6% | — | ||
| Q2 25 | -22.8% | — | ||
| Q1 25 | -16.0% | — | ||
| Q4 24 | -8.1% | — | ||
| Q3 24 | -21.4% | — | ||
| Q2 24 | -24.2% | — | ||
| Q1 24 | -29.4% | — |
| Q4 25 | 1.0% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 12.7% | — | ||
| Q1 24 | 14.5% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
